Publications related to project ENDFLU – part 2

The Consortium is proud to present a new round of publications related to ENDFLU. Earlier publications can be found here.

#TitleAuthorsJournalDOI and URL
7Mosaic N1 and N2 neuraminidase nanoparticles induce high antibody titers and potent
protection from Influenza A virus H1N1 and H3N2 challenge
Mirte Pascha, Marlies Ballegeer, Irina Albulescu, Berend Jan Bosch, Frank J.M. van Kuppeveld, Xavier Saelens, Cornelis A.M. de HaanPublication in conference proceedings/workshopN.a.
8Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In VivoSneha Raj, Preeti Vishwakarma, Shikha Saxena, Varun Kumar, Ritika Khatri, Amit Kumar, Mrityunjay Singh, Surbhi Mishra, Shailendra Asthana, Shubbir Ahmed, Sweety SamalVaccines10.3390/vaccines11040780
View here
9Computational design of vaccine immunogensKarla M Castro, Andreas Scheck, Shuhao Xiao, Bruno E CorreiaCurrent Opinion in Biotechnology10.1016/j.copbio.2022.102821 View here
10Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in MiceMartin C. Langenmayer, Anna-Theresa Luelf-Averhoff, Lisa Marr, Sylvia Jany, Astrid Freudenstein, Silvia Adam-Neumair, Alina Tscherne, Robert Fux, Juan J. Rojas, Andreas Blutke, Gerd Sutter, Asisa VolzPathogens10.3390/pathogens12070867 View here
11Chapter 2 - Deep mutational scanning to probe specificity determinants in proteinsJayantika Bhowmick, Soumyanetra Chandra, Raghavan VaradarajanFoundations and Frontiers in Enzymology10.1016/B978-0-323-99533-7.00005-4 View here
12Biophysical Correlates of Enhanced Immunogenicity of a Stabilized Variant of the Receptor Binding Domain of SARS-CoV-2.Kawkab Kanjo, Gopinath Chattopadhyay, Sameer Kumar Malladi, Randhir Singh, Sowrabha Jayatheertha, Raghavan VaradarajanThe Journal of Physical Chemistry B10.1021/acs.jpcb.2c07262 View here
13Design and evaluation of a poly-epitope based vaccine for the induction of influenza A virus cross-reactive CD8+ T cell responses In preparation
14Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell ImmunityBram Van Den Eeckhout, Marlies Ballegeer, Jozefien De Clercq, Elianne Burg, Xavier Saelens, Linos Vandekerckhove, Sarah GerloInternational Journal of Molecular Sciences10.3390/ijms242115770View here
15Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza A virus challengeM. N. Pascha, M. Ballegeer, M. C. Roelofs, L. Meuris, I. C. Albulescu, F. J. M. van Kuppeveld, D. L. Hurdiss, B. J. Bosch, T. Zeev-Ben-Mordehai, X. Saelens, C. A. M. de Haannpj Vaccines10.1038/s41541-024-00891-3 View here

Related Posts